Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	MATN2 MATN4 C2CD5 HMCN2 BRAF PCDH19 EEF2K PLCB3 NOTCH4 PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 ITSN1 ANXA7 PCDHA1 GSN EYS SLC25A12 CELSR3 GLCE VCAN MACF1 EGFLAM	2.42e-06	749	248	26	GO:0005509
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNAH8 DNHD1 DNAH10 DNAH11	6.20e-05	18	248	4	GO:0008569
GeneOntologyMolecularFunction	growth factor binding	HTRA1 NLRP7 TGFBR3L INSR FGFR4 HAP1 NLRP2 WFIKKN1 FURIN	1.49e-04	156	248	9	GO:0019838
GeneOntologyMolecularFunction	ATP-dependent activity	ABCA1 TDRD9 MYO9A TOR4A CHD3 MOCS3 STARD9 DNAH8 ABCC10 DNHD1 DDX31 DNAH10 SMARCAL1 CHTF18 HELZ2 MACF1 ATP1A1 ATP2B1 DNAH11	2.56e-04	614	248	19	GO:0140657
GeneOntologyCellularComponent	9+2 non-motile cilium	STRC STRCP1 CDC14A IFT88	1.71e-05	14	246	4	GO:0097732
GeneOntologyCellularComponent	kinocilium	STRC STRCP1 CDC14A IFT88	1.71e-05	14	246	4	GO:0060091
Domain	Cadherin_tail	PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 PCDHA1	3.82e-07	37	239	7	PF15974
Domain	Cadherin_CBD	PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 PCDHA1	3.82e-07	37	239	7	IPR031904
Domain	Cadherin_2	PCDH19 PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 PCDHA1	1.72e-06	65	239	8	PF08266
Domain	Cadherin_N	PCDH19 PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 PCDHA1	1.72e-06	65	239	8	IPR013164
Domain	Cadherin_CS	PCDH19 PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 PCDHA1 CELSR3	1.11e-05	109	239	9	IPR020894
Domain	CADHERIN_1	PCDH19 PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 PCDHA1 CELSR3	1.49e-05	113	239	9	PS00232
Domain	Cadherin	PCDH19 PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 PCDHA1 CELSR3	1.49e-05	113	239	9	PF00028
Domain	-	PCDH19 PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 PCDHA1 CELSR3	1.60e-05	114	239	9	2.60.40.60
Domain	CADHERIN_2	PCDH19 PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 PCDHA1 CELSR3	1.60e-05	114	239	9	PS50268
Domain	CA	PCDH19 PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 PCDHA1 CELSR3	1.71e-05	115	239	9	SM00112
Domain	Cadherin-like	PCDH19 PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 PCDHA1 CELSR3	1.84e-05	116	239	9	IPR015919
Domain	Cadherin	PCDH19 PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 PCDHA1 CELSR3	2.11e-05	118	239	9	IPR002126
Domain	MT	DNAH8 DNHD1 DNAH10 DNAH11	2.37e-05	14	239	4	PF12777
Domain	Dynein_HC_stalk	DNAH8 DNHD1 DNAH10 DNAH11	2.37e-05	14	239	4	IPR024743
Domain	Dynein_heavy_dom-2	DNAH8 DNHD1 DNAH10 DNAH11	2.37e-05	14	239	4	IPR013602
Domain	DHC_N2	DNAH8 DNHD1 DNAH10 DNAH11	2.37e-05	14	239	4	PF08393
Domain	DHC_fam	DNAH8 DNHD1 DNAH10 DNAH11	3.19e-05	15	239	4	IPR026983
Domain	Dynein_heavy	DNAH8 DNHD1 DNAH10 DNAH11	3.19e-05	15	239	4	PF03028
Domain	Dynein_heavy_dom	DNAH8 DNHD1 DNAH10 DNAH11	3.19e-05	15	239	4	IPR004273
Domain	EGF	NRG1 MATN2 MATN4 NOTCH4 TNC EYS CELSR3 VCAN EGFLAM	3.56e-05	126	239	9	PF00008
Domain	DHC_N1	DNAH8 DNAH10 DNAH11	1.11e-04	8	239	3	PF08385
Domain	Dynein_heavy_dom-1	DNAH8 DNAH10 DNAH11	1.11e-04	8	239	3	IPR013594
Domain	EGF_CA	MATN2 MATN4 HMCN2 NOTCH4 EYS CELSR3 VCAN EGFLAM	1.76e-04	122	239	8	SM00179
Domain	Growth_fac_rcpt_	HTRA1 MATN2 INSR MATN4 HMCN2 NOTCH4 TNC EYS FURIN	1.85e-04	156	239	9	IPR009030
Domain	Cadherin_C	PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5	1.90e-04	42	239	5	IPR032455
Domain	Cadherin_C_2	PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5	1.90e-04	42	239	5	PF16492
Domain	EGF-like_Ca-bd_dom	MATN2 MATN4 HMCN2 NOTCH4 EYS CELSR3 VCAN EGFLAM	1.97e-04	124	239	8	IPR001881
Domain	ASX_HYDROXYL	MATN2 MATN4 HMCN2 NOTCH4 EYS CELSR3 VCAN	3.00e-04	100	239	7	PS00010
Domain	EGF-type_Asp/Asn_hydroxyl_site	MATN2 MATN4 HMCN2 NOTCH4 EYS CELSR3 VCAN	4.28e-04	106	239	7	IPR000152
Domain	Stereocilin-rel	STRC OTOA	4.85e-04	3	239	2	IPR026664
Domain	HAP1_N	HAP1 TRAK2	4.85e-04	3	239	2	IPR006933
Domain	HAP1_N	HAP1 TRAK2	4.85e-04	3	239	2	PF04849
Domain	AAA+_ATPase	ABCA1 TOR4A DNAH8 ABCC10 DNAH10 CHTF18 HELZ2 DNAH11	5.40e-04	144	239	8	IPR003593
Domain	AAA	ABCA1 TOR4A DNAH8 ABCC10 DNAH10 CHTF18 HELZ2 DNAH11	5.40e-04	144	239	8	SM00382
Domain	VWFA	MATN2 MATN4 HMCN2 COL6A3 VWF CACHD1	6.42e-04	82	239	6	PS50234
Domain	ATPase_dyneun-rel_AAA	DNAH8 DNAH10 DNAH11	6.79e-04	14	239	3	IPR011704
Domain	AAA_8	DNAH8 DNAH10 DNAH11	6.79e-04	14	239	3	PF12780
Domain	AAA_5	DNAH8 DNAH10 DNAH11	6.79e-04	14	239	3	PF07728
Domain	Dynein_heavy_chain_D4_dom	DNAH8 DNAH10 DNAH11	6.79e-04	14	239	3	IPR024317
Domain	VWA	MATN2 MATN4 HMCN2 COL6A3 VWF CACHD1	7.29e-04	84	239	6	SM00327
Domain	VWA	MATN2 MATN4 COL6A3 VWF CACHD1	7.39e-04	56	239	5	PF00092
Domain	IGc2	SNHG28 NRG1 LRRC24 LRFN4 HMCN2 FGFR4 IGDCC3 WFIKKN1 FCRL5 LRIT1	9.27e-04	235	239	10	SM00408
Domain	EGF_3	NRG1 MATN2 MATN4 HMCN2 NOTCH4 TNC EYS CELSR3 VCAN EGFLAM	9.27e-04	235	239	10	PS50026
Domain	Ig_sub2	SNHG28 NRG1 LRRC24 LRFN4 HMCN2 FGFR4 IGDCC3 WFIKKN1 FCRL5 LRIT1	9.27e-04	235	239	10	IPR003598
Domain	NGF	NGF NTF4	9.62e-04	4	239	2	PF00243
Domain	NGF_1	NGF NTF4	9.62e-04	4	239	2	PS00248
Domain	NGF	NGF NTF4	9.62e-04	4	239	2	SM00140
Domain	Nerve_growth_factor-rel	NGF NTF4	9.62e-04	4	239	2	PD002052
Domain	-	MATN2 MATN4	9.62e-04	4	239	2	1.20.5.30
Domain	Matrilin_coiled-coil_trimer	MATN2 MATN4	9.62e-04	4	239	2	IPR019466
Domain	Nerve_growth_factor-like	NGF NTF4	9.62e-04	4	239	2	IPR020408
Domain	Nerve_growth_factor_CS	NGF NTF4	9.62e-04	4	239	2	IPR019846
Domain	Matrilin_ccoil	MATN2 MATN4	9.62e-04	4	239	2	SM01279
Domain	Matrilin_ccoil	MATN2 MATN4	9.62e-04	4	239	2	PF10393
Domain	NGF_2	NGF NTF4	9.62e-04	4	239	2	PS50270
Domain	Nerve_growth_factor-rel	NGF NTF4	9.62e-04	4	239	2	IPR002072
Domain	EGF-like_dom	NRG1 MATN2 MATN4 HMCN2 NOTCH4 TNC EYS CELSR3 VCAN EGFLAM	1.43e-03	249	239	10	IPR000742
Domain	VWF_A	MATN2 MATN4 HMCN2 COL6A3 VWF CACHD1	1.72e-03	99	239	6	IPR002035
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	LRRC24 SREBF1 TOR4A PLXND1 ACOX3 TYK2 NCAPD2 C19orf44 COBL MAFF MCF2L ABTB2 TRAPPC9 ABCC10 RTL6 SPOUT1 POLG FBRSL1 FAAP100 HIVEP3 KMT2D CELSR3 RPAP1 MROH6 FURIN MARK4 HELZ2 OGDHL PC PRRT4	5.25e-10	1105	250	30	35748872
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	RALGAPA1 HTRA1 MYO9A GFAP STARD9 DAGLA AGAP2 HAP1 TNC ARHGAP39 SHANK3 CSNK1E VCAN MARK4 MACF1 PC ATP2B1	1.82e-08	430	250	17	32581705
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RALGAPA1 MYO9A SIK1 TRIP11 BRAF NFATC3 STARD9 ZNF286B COBL FNIP1 NHS GNAS ABTB2 TRAPPC9 USP43 SIK3 ZNRF2 CDC14A SH3PXD2A CSNK1E MARK4 MACF1 PC ATP2B1	1.92e-08	861	250	24	36931259
Pubmed	A striking organization of a large family of human neural cadherin-like cell adhesion genes.	PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 PCDHA1 CELSR3	5.13e-08	72	250	8	10380929
Pubmed	Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes.	PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 PCDHA1 CELSR3	1.18e-07	80	250	8	10716726
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RALGAPA1 MYO9A SRC INSR CHD3 TYK2 PTPRE ERI3 ANKIB1 COBL FNIP1 GNAS MCF2L DAGLA TRAPPC9 LMF1 POLG ANXA7 FBRSL1 E2F3 ARHGAP39 SLC35F5 HIVEP3 SH3PXD2A SLC22A3 PANK4 TJAP1 MACF1 AADAT ATP2B1	3.99e-07	1489	250	30	28611215
Pubmed	Comparative DNA sequence analysis of mouse and human protocadherin gene clusters.	PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 PCDHA1	6.08e-07	68	250	7	11230163
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	NLRP7 TRO EML6 MMP21 SIK1 CHD3 PRPF6 CLCN4 STARD9 NCAPD2 DLEC1 MCF2L DNAH8 AGAP2 RARRES1 PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 ITSN1 SLC25A12 IFT88 SH3PXD2A OGDHL MACF1 ATP1A1 ATP2B1	6.57e-07	1442	250	29	35575683
Pubmed	Cadherin superfamily genes: functions, genomic organization, and neurologic diversity.	PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 PCDHA1	1.09e-06	74	250	7	10817752
Pubmed	Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members.	PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 PCDHA1	1.43e-06	77	250	7	10835267
Pubmed	Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism.	SIK1 GNAS SIK3	1.46e-06	4	250	3	29941929
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	RALGAPA1 HTRA1 MYO9A ZNF185 CHD3 TRIP11 GFAP DAGLA PLPPR2 TRAPPC9 AGAP2 CACNA1A VWF TNC ITSN1 ARHGAP39 SHANK3 GSN RIN1 SLC25A12 LGI3 VCAN OGDHL MACF1 ATP1A1 PC ATP2B1 DNAH11	1.77e-06	1431	250	28	37142655
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	HTRA1 MATN2 MATN4 HMCN2 COL6A3 VWF TNC ANXA7 VCAN	3.70e-06	167	250	9	22159717
Pubmed	Functional significance of isoform diversification in the protocadherin gamma gene cluster.	SRC GFAP PCDHGB2 PCDHGA11 SLC18A3	4.33e-06	34	250	5	22884324
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	SRC C2CD5 AGAP2 CACNA1A TNC ITSN1 ARHGAP39 RIN1 SH3PXD2A MACF1 ATP1A1 SNTB2	9.21e-06	347	250	12	17114649
Pubmed	Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.	HTRA1 MATN2 HMCN2 COL6A3 VWF TNC GSN VCAN	1.14e-05	146	250	8	27068509
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	SRC INSR TRIP11 C2CD5 PARD6A PCDH19 COBL NHS CACHD1 MACF1 ATP1A1 ATP2B1 XPR1	1.31e-05	421	250	13	36976175
Pubmed	Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c.	HTRA1 GLB1L MATN2 QSOX1 NGF VWF TNC CXCL2 GSN VCAN	1.39e-05	248	250	10	24006456
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	C2CD5 ZNF286B TRAPPC9 MIER2 ARHGAP39 SHANK3 HIVEP3 LDB3 GLCE HELZ2 UBR3 MACF1 FHDC1 MAST3	1.55e-05	493	250	14	15368895
Pubmed	FGF/FGFR2 signaling regulates the generation and correct positioning of Bergmann glia cells in the developing mouse cerebellum.	GFAP FGFR4 TNC SLC18A3	2.93e-05	25	250	4	24983448
Pubmed	Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation.	SRC TYK2 FGF8 FGFR4	2.93e-05	25	250	4	11294897
Pubmed	New genetic associations detected in a host response study to hepatitis B vaccine.	EFS TRO PRPF6 SSTR4 NFATC3 TMEM70 CCDC78 ALDH3A1 CCR10 BIRC3 CXCL2 LIMS2 RAVER2 GAB3 MACF1 IRGC FCRL5 LRIT1	3.33e-05	824	250	18	20237496
Pubmed	Tks5-dependent formation of circumferential podosomes/invadopodia mediates cell-cell fusion.	SRC SH3PXD2A	5.15e-05	2	250	2	22584907
Pubmed	Bergmann glial development in the mouse cerebellum as revealed by tenascin expression.	GFAP TNC	5.15e-05	2	250	2	8849669
Pubmed	Preferred sequence requirements for cleavage of pro-von Willebrand factor by propeptide-processing enzymes.	VWF FURIN	5.15e-05	2	250	2	1571548
Pubmed	Differential Effects of Furin Deficiency on Insulin Receptor Processing and Glucose Control in Liver and Pancreatic β Cells of Mice.	INSR FURIN	5.15e-05	2	250	2	34198511
Pubmed	NLRP2 controls age-associated maternal fertility.	NLRP7 NLRP2	5.15e-05	2	250	2	27881734
Pubmed	Involvement of tenascin-C and PG-M/versican in flexor tenosynovial pathology of idiopathic carpal tunnel syndrome.	TNC VCAN	5.15e-05	2	250	2	16493581
Pubmed	The Na/K-ATPase α1/Src interaction regulates metabolic reserve and Western diet intolerance.	SRC ATP1A1	5.15e-05	2	250	2	33752256
Pubmed	Cytosolic protein tyrosine phosphatase-epsilon is a negative regulator of insulin signaling in skeletal muscle.	INSR PTPRE	5.15e-05	2	250	2	18006633
Pubmed	E3 ubiquitin ligase RNF123-deficient mice exhibit reduced parasitemia and mortality in rodent malaria (Plasmodium yoelii 17XL) infection.	RNF13 RNF123	5.15e-05	2	250	2	35063657
Pubmed	Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas.	FGFR4 GNAS	5.15e-05	2	250	2	18070145
Pubmed	Compartment-specific multiomic profiling identifies SRC and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma.	SRC GNAS	5.15e-05	2	250	2	38097740
Pubmed	The association of phosphoinositide 3-kinase enhancer A with hepatic insulin receptor enhances its kinase activity.	INSR AGAP2	5.15e-05	2	250	2	21720388
Pubmed	NLRP2 inflammasome in dorsal root ganglion as a novel molecular platform that produces inflammatory pain hypersensitivity.	NLRP7 NLRP2	5.15e-05	2	250	2	31162334
Pubmed	TRAK2, a novel regulator of ABCA1 expression, cholesterol efflux and HDL biogenesis.	ABCA1 TRAK2	5.15e-05	2	250	2	28655204
Pubmed	Interaction between the insulin receptor and Grb14: a dynamic study in living cells using BRET.	INSR GRB14	5.15e-05	2	250	2	16934761
Pubmed	Receptor-type protein tyrosine phosphatase epsilon (PTPepsilonM) is a negative regulator of insulin signaling in primary hepatocytes and liver.	INSR PTPRE	5.15e-05	2	250	2	15738637
Pubmed	NLRP2 is highly expressed in a mouse model of ischemic stroke.	NLRP7 NLRP2	5.15e-05	2	250	2	27693696
Pubmed	A Src-Tks5 pathway is required for neural crest cell migration during embryonic development.	SRC SH3PXD2A	5.15e-05	2	250	2	21799874
Pubmed	Expression of a human proprotein processing enzyme: correct cleavage of the von Willebrand factor precursor at a paired basic amino acid site.	VWF FURIN	5.15e-05	2	250	2	2251280
Pubmed	A genetic association study of NLRP2 and NLRP7 genes in idiopathic recurrent miscarriage.	NLRP7 NLRP2	5.15e-05	2	250	2	23360675
Pubmed	Modifying murine von Willebrand factor A1 domain for in vivo assessment of human platelet therapies.	ITGA2B VWF	5.15e-05	2	250	2	18084279
Pubmed	GMAP210 and IFT88 are present in the spermatid golgi apparatus and participate in the development of the acrosome-acroplaxome complex, head-tail coupling apparatus and tail.	TRIP11 IFT88	5.15e-05	2	250	2	21337470
Pubmed	Tks5 SH3 domains exhibit differential effects on invadopodia development.	SRC SH3PXD2A	5.15e-05	2	250	2	31999741
Pubmed	Nlrp2, a maternal effect gene required for early embryonic development in the mouse.	NLRP7 NLRP2	5.15e-05	2	250	2	22295082
Pubmed	Salt-inducible kinase regulates hepatic lipogenesis by controlling SREBP-1c phosphorylation.	SREBF1 SIK1	5.15e-05	2	250	2	19244231
Pubmed	Development of astrocytes in the mouse hippocampus as tracked by tenascin-C gene expression.	GFAP TNC	5.15e-05	2	250	2	11436985
Pubmed	Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer.	TNC VCAN	5.15e-05	2	250	2	15073129
Pubmed	Are CRH & NGF as psychoneuroimmune regulators in women with polycystic ovary syndrome?	NGF CRH	5.15e-05	2	250	2	27908212
Pubmed	Reproductive Outcomes from Maternal Loss of Nlrp2 Are Not Improved by IVF or Embryo Transfer Consistent with Oocyte-Specific Defect.	NLRP7 NLRP2	5.15e-05	2	250	2	33090377
Pubmed	Nuclear localization of Annexin A7 during murine brain development.	GFAP ANXA7	5.15e-05	2	250	2	15819996
Pubmed	Fibroblasts can express glial fibrillary acidic protein (GFAP) in vivo.	SRC GFAP	5.15e-05	2	250	2	11379820
Pubmed	Microexon-based regulation of ITSN1 and Src SH3 domains specificity relies on introduction of charged amino acids into the interaction interface.	SRC ITSN1	5.15e-05	2	250	2	20659428
Pubmed	Extracellular matrix changes in corneal opacification vary depending on etiology.	MATN2 TNC	5.15e-05	2	250	2	33633437
Pubmed	Expression of mouse Tbx22 supports its role in palatogenesis and glossogenesis.	TBX22 CACNA1A	5.15e-05	2	250	2	12666195
Pubmed	Dual-vector gene therapy restores cochlear amplification and auditory sensitivity in a mouse model of DFNB16 hearing loss.	STRC STRCP1	5.15e-05	2	250	2	34910522
Pubmed	Suppressing NLRP2 expression accelerates hepatic steatosis: A mechanism involving inflammation and oxidative stress.	NLRP7 NLRP2	5.15e-05	2	250	2	30454891
Pubmed	Structural basis for inhibition of the insulin receptor by the adaptor protein Grb14.	INSR GRB14	5.15e-05	2	250	2	16246733
Pubmed	Oleic acid modulates mRNA expression of liver X receptor (LXR) and its target genes ABCA1 and SREBP1c in human neutrophils.	ABCA1 SREBF1	5.15e-05	2	250	2	24722912
Pubmed	Selective inactivation of the Arg-Gly-Asp-Ser (RGDS) binding site in von Willebrand factor by site-directed mutagenesis.	ITGA2B VWF	5.15e-05	2	250	2	1737795
Pubmed	Gelsolin domain 2 Ca2+ affinity determines susceptibility to furin proteolysis and familial amyloidosis of finnish type.	GSN FURIN	5.15e-05	2	250	2	14596804
Pubmed	Mutations in a new gene encoding a protein of the hair bundle cause non-syndromic deafness at the DFNB16 locus.	STRC STRCP1	5.15e-05	2	250	2	11687802
Pubmed	Tyrosine phosphatase epsilonM stimulates migration and survival of porcine aortic endothelial cells by activating c-Src.	SRC PTPRE	5.15e-05	2	250	2	15522235
Pubmed	A new method for isolating tyrosine kinase substrates used to identify fish, an SH3 and PX domain-containing protein, and Src substrate.	SRC SH3PXD2A	5.15e-05	2	250	2	9687503
Pubmed	Cryo-EM structure of activated bile acids receptor TGR5 in complex with stimulatory G protein.	GNAS GPBAR1	5.15e-05	2	250	2	32747649
Pubmed	Secondary ossification center induces and protects growth plate structure.	GNAS SIK3	5.15e-05	2	250	2	33063669
Pubmed	Src kinase regulation by phosphorylation and dephosphorylation.	SRC PTPRE	5.15e-05	2	250	2	15845350
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	HGH1 STARD9 ANKIB1 NOTCH4 CACNA1A ANKZF1 SHANK3 SLC18A3 DNAH11	5.24e-05	233	250	9	37704626
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	COQ2 ERVK-25 GNAS CACNA1A VWF PCDHGA11 GPX2 PCDHA1 XPNPEP2 KMT2D HELZ2 INS-IGF2 MAST3 DNAH11	5.31e-05	552	250	14	10737800
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	EFS GFAP QSOX1 ERI3 ANKIB1 COBL VWF TNC ITSN1 SHANK3 LIMS2 IFT88 CHRD TJAP1	6.19e-05	560	250	14	21653829
Pubmed	Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors.	RUSC1 FASTKD5 TOR4A COQ2 TULP2 DHODH GRIN3B RIN1 SLC18A3 CHTF18 ATP1A1	6.50e-05	359	250	11	35559673
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	ABCA1 ZSCAN5DP ZNF648 NHS COL6A3 SPOUT1 TNC ANKZF1 GSN OGDHL ATP2B1	7.17e-05	363	250	11	14691545
Pubmed	Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.	SRC TYK2 FGFR4	7.70e-05	12	250	3	10918587
Pubmed	The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors.	MATN2 SRC TRIP11 TYK2 FGFR4 VWF	8.33e-05	99	250	6	19730683
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	SF3A1 SRC INSR SIK1 FASTKD5 ACOX3 C2CD5 BRAF FGFR4 F2RL3 FBRSL1 SIK3 LIMS2 AIFM1 SH3PXD2A CSNK1E SNTB2 MAST3	1.17e-04	910	250	18	36736316
Pubmed	Intrahepatic bile ducts guide establishment of the intrahepatic nerve network in developing and regenerating mouse liver.	NGF NTF4 SLC18A3	1.26e-04	14	250	3	29615468
Pubmed	p130Cas: a versatile scaffold in signaling networks.	SRC ITGA2B VWF	1.26e-04	14	250	3	16581250
Pubmed	Identification of dynein heavy chain genes expressed in human and mouse testis: chromosomal localization of an axonemal dynein gene.	DNAH8 DNAH10 DNAH11	1.26e-04	14	250	3	9373155
Pubmed	Maternal insulin resistance and transient hyperglycemia impact the metabolic and endocrine phenotypes of offspring.	INSR SREBF1 INS-IGF2	1.26e-04	14	250	3	25249504
Pubmed	Integrins and Src: dynamic duo of adhesion signaling.	SRC ITGA2B VWF	1.26e-04	14	250	3	16005629
Pubmed	Lmx1a maintains proper neurogenic, sensory, and non-sensory domains in the mammalian inner ear.	FGF8 WNT2B TLX3	1.26e-04	14	250	3	19540218
Pubmed	Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.	MATN2 COL6A3 VWF TNC ANXA7 WNT2B VCAN	1.27e-04	153	250	7	25037231
Pubmed	Genetic mapping of the mouse ferritin light chain gene and 11 pseudogenes on 11 mouse chromosomes.	NGF PLCB3 NOTCH4 VCAN	1.28e-04	36	250	4	9457670
Pubmed	Loss of the Maternal Effect Gene Nlrp2 Alters the Transcriptome of Ovulated Mouse Oocytes and Impacts Expression of Histone Demethylase KDM1B.	NLRP7 NLRP2	1.54e-04	3	250	2	36976514
Pubmed	Insulin protects acinar cells during pancreatitis by preserving glycolytic ATP supply to calcium pumps.	INSR INS-IGF2	1.54e-04	3	250	2	34282152
Pubmed	Absence of GNAS and BRAF mutations but presence of KRAS mutation in urachal adenocarcinoma.	BRAF GNAS	1.54e-04	3	250	2	28285720
Pubmed	Nitric oxide inhibits von Willebrand factor-mediated platelet adhesion and spreading through regulation of integrin alpha(IIb)beta(3) and myosin light chain.	ITGA2B VWF	1.54e-04	3	250	2	19765213
Pubmed	Cochlear outer hair cell horizontal top connectors mediate mature stereocilia bundle mechanics.	STRC STRCP1	1.54e-04	3	250	2	30801007
Pubmed	Quantitative proteomics and integrative network analysis identified novel genes and pathways related to osteoporosis.	ITGA2B GSN	1.54e-04	3	250	2	27153759
Pubmed	Maternal variants in NLRP and other maternal effect proteins are associated with multilocus imprinting disturbance in offspring.	NLRP7 NLRP2	1.54e-04	3	250	2	29574422
Pubmed	Clic1 plays a role in mouse hepatocarcinoma via modulating Annexin A7 and Gelsolin in vitro and in vivo.	ANXA7 GSN	1.54e-04	3	250	2	25661391
Pubmed	Tenascin-C deposition requires beta3 integrin and Src.	SRC TNC	1.54e-04	3	250	2	15336554
Pubmed	Src induces expression of carbonic anhydrase IX via hypoxia-inducible factor 1.	SRC CA9	1.54e-04	3	250	2	20127031
Pubmed	Direct interaction between ER membrane-bound PTP1B and its plasma membrane-anchored targets.	SRC INSR	1.54e-04	3	250	2	17092689
Pubmed	Phosphorylated Grb14 is an endogenous inhibitor of retinal protein tyrosine phosphatase 1B, and light-dependent activation of Src phosphorylates Grb14.	SRC GRB14	1.54e-04	3	250	2	21791607
Pubmed	Developmental regulation and asymmetric expression of the gene encoding Cx43 gap junctions in the mouse limb bud.	FGF8 DNAH11	1.54e-04	3	250	2	9438343
Pubmed	The proprotein convertase furin is a pro-oncogenic driver in KRAS and BRAF driven colorectal cancer.	BRAF FURIN	1.54e-04	3	250	2	32139876
Pubmed	Uncoupling of Pyrin-only protein 2 (POP2)-mediated dual regulation of NF-κB and the inflammasome.	NLRP7 NLRP2	1.54e-04	3	250	2	21976665
Pubmed	Inhibition of insulin receptor catalytic activity by the molecular adapter Grb14.	INSR GRB14	1.54e-04	3	250	2	11726652
Cytoband	5q31	PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 PCDHA1	3.47e-06	115	250	7	5q31
Cytoband	8q24.3	LRRC24 HGH1 ZNF696 TRAPPC9 ARHGAP39 MROH6	3.81e-05	113	250	6	8q24.3
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	FNIP1 PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 PCDHA1 RNF14	4.22e-05	298	250	9	chr5q31
GeneFamily	Clustered protocadherins	PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 PCDHA1	1.79e-06	64	164	7	20
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	NRG1 LRRC24 LRFN4 HMCN2 FGFR4 IGDCC3 WFIKKN1 LRIT1	1.12e-04	161	164	8	593
GeneFamily	Dyneins, axonemal	DNAH8 DNAH10 DNAH11	4.54e-04	17	164	3	536
GeneFamily	PDZ domain containing	HTRA1 PARD6A PDLIM2 SHANK3 LDB3 SNTB2 MAST3	4.78e-04	152	164	7	1220
GeneFamily	Fibronectin type III domain containing	INSR FNDC1 LRFN4 TNC IGDCC3 EGFLAM LRIT1	6.49e-04	160	164	7	555
GeneFamily	Zinc fingers BED-type\|Pseudoautosomal region 1	ZBED6 ZBED1	1.20e-03	6	164	2	64
GeneFamily	LIM domain containing	ZNF185 PDLIM2 NRAP LDB3	2.02e-03	59	164	4	1218
Coexpression	HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN	SNHG28 NRG1 HTRA1 GLB1L INSR ZNF185 FFAR4 QSOX1 CLCN4 NHS EEF2K PLPPR2 OTOA COL6A3 VWF RARRES1 CACHD1 GSN MROH6 VCAN TRIM47 PC ATP2B1	5.89e-07	740	246	23	M41202
Coexpression	GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_UP	SF3A1 MATN2 GPLD1 CDC14A SLC35F5 HIVEP3 IFT88 CHTF18 SPRED1 FCRL5	4.54e-06	168	246	10	M8823
Coexpression	MENON_FETAL_KIDNEY_3_STROMAL_CELLS	CHD3 GNAS COL6A3 TNC VCAN MACF1 ATP2B1	1.13e-05	81	246	7	M39253
Coexpression	LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN	MATN4 SSTR4 STARD9 FGFR4 TRAPPC9 NOTCH4 DENND5B SHANK3 GSN LIMS2 LGI3 SLC22A3 RAVER2 GAB3 MACF1 GRAP	1.83e-05	491	246	16	MM455
Coexpression	BILD_E2F3_ONCOGENIC_SIGNATURE	INSR EML6 SREBF1 PLXND1 NFATC3 GNAS ABCC10 TNC SHANK3 SLC25A12 RAVER2	2.47e-05	248	246	11	M13061
ToppCell	5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	INSR PLXND1 MCF2L NOTCH4 MIER2 VWF F2RL3 SHANK3 GSN LIMS2 P2RY6	1.44e-08	196	248	11	c5fe470f11ee4962bcfb30cddfd8c078af5b1222
ToppCell	droplet-Heart-4Chambers-18m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RUSC1 PLXND1 MCF2L NOTCH4 DENND5B VWF PCDHGA11 SHANK3 LIMS2 OGDHL	5.00e-08	173	248	10	9a04271c51fae34f547db3206f9ff5857686e45c
ToppCell	COVID-19-kidney-PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	INSR PLXND1 PTPRE MCF2L NOTCH4 VWF F2RL3 SHANK3 LIMS2 MACF1	1.53e-07	195	248	10	a436483fec137584611f86b7a498a4dc2aa19cd3
ToppCell	Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a7-Tac2-Excitatory_Neuron.Slc17a7.Tac2.Syt15_(Medial_habenula)\|Thalamus / BrainAtlas - Mouse McCarroll V32	TDRD9 SSTR4 FGFR4 NTF4 WNT2B GPX2 SLC18A3	2.46e-07	77	248	7	7f624e9262bd0dc2ac4176f43c91a4bc0f521fe5
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CHD3 FNDC1 CHRNA10 PLPPR2 AGAP2 COL6A3 B3GALT6 CHTF18 VCAN	3.13e-07	161	248	9	a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CHD3 FNDC1 CHRNA10 PLPPR2 AGAP2 COL6A3 B3GALT6 CHTF18 VCAN	3.13e-07	161	248	9	08920a716f6ec62538e361211455a30ad726d7be
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAB21L4 EML6 MATN4 DAGLA ABCC10 CACNA1A NTF4 LGI3 PC	6.32e-07	175	248	9	96219e58dcb327fd27190be78193e7a0d611e62b
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MAB21L4 EML6 MATN4 DAGLA ABCC10 CACNA1A NTF4 LGI3 PC	6.32e-07	175	248	9	cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa
ToppCell	P15-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MATN2 SREBF1 FASTKD5 GFAP C2CD5 NHS B3GALT6 SPRED1 MAST3	6.63e-07	176	248	9	792f414f5092aba14260b8e16378e793a822498e
ToppCell	droplet-Heart-4Chambers-18m-Endothelial-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RUSC1 PLXND1 MCF2L NOTCH4 DENND5B USP43 SHANK3 LIMS2 OGDHL	7.28e-07	178	248	9	ba2f0585626988b511046630bc16be5c5fec3fb2
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLXND1 NOTCH4 VWF WNT2B CXCL2 SHANK3 GSN SSUH2 LIMS2	1.25e-06	190	248	9	bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RCSD1 PLXND1 PTPRE STARD9 NOTCH4 SHANK3 LIMS2 HIVEP3 MARK4	1.31e-06	191	248	9	f663131a4810584c5854bd64ee7991a237b7707f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HMCN2 PTPRE NOTCH4 VWF SHANK3 GSN LIMS2 MARK4 XPR1	1.37e-06	192	248	9	3259cb89d6bcf0a3c6ff1f64d85e8a1f54124e91
ToppCell	droplet-Bladder-BLADDER-1m-Endothelial-endothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RCSD1 PLXND1 FAM181B MCF2L NOTCH4 VWF SHANK3 TRIM47 GRAP	1.43e-06	193	248	9	88cd7d0d0da5c776b49fc131f746fe5ad9676fb7
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	INSR PLXND1 HMCN2 NOTCH4 VWF WNT2B SHANK3 GSN LIMS2	1.55e-06	195	248	9	6bdef651cf73d7381e5012d0eb3c809138fb6b92
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	INSR PLXND1 NOTCH4 VWF F2RL3 CACHD1 SHANK3 LIMS2 GRAP	1.69e-06	197	248	9	c10dd1aaec01fb662eac83dfde90e3e426665d65
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	INSR PLXND1 NOTCH4 VWF F2RL3 CACHD1 SHANK3 LIMS2 GRAP	1.69e-06	197	248	9	2844dbcd0a673ed81c99920aa45858651a00736d
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-F\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NRG1 TDRD9 PTPRE MIER2 CXCL2 ZBED6 VCAN ATP2B1 MAST3	1.69e-06	197	248	9	4a6eff66a17c5e89bda61d887b736f5c62b93bd7
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HTRA1 MATN2 NGF PDLIM2 COL6A3 TNC NTF4 WNT2B VCAN	1.76e-06	198	248	9	9541d68a1a6247dbd7161a62644eea6527c2c8ff
ToppCell	metastatic_Brain-Endothelial_cells-Tumor_ECs\|metastatic_Brain / Location, Cell class and cell subclass	HTRA1 INSR PCDH19 MCF2L NOTCH4 VWF SHANK3 LIMS2 GRAP	1.76e-06	198	248	9	5e274f29cc796dae7d64d6035e904816c25f9914
ToppCell	3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HTRA1 INSR NOTCH4 VWF F2RL3 SHANK3 GSN LIMS2 P2RY6	1.76e-06	198	248	9	e9e98c20ff7b3f3851db86381550ce7085e2db9e
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HTRA1 NGF COL6A3 RARRES1 XPNPEP2 GSN VCAN CHRD HAS1	1.92e-06	200	248	9	14f3fe19b6647b32a5e28d717235741997d8522c
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRG1 NHS STRC DNHD1 TNC FBRSL1 HIVEP3 WFIKKN1	3.01e-06	158	248	8	7f5426585d0d299d2b48e5fcb349950feffdef33
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	RGMB DLEC1 MCF2L SPOUT1 CDC14A CHTF18 TJAP1 TRAK2	3.46e-06	161	248	8	5fba13f0aa5002f7eefe219e2c6a07e163f1a50d
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-5\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PARD6A STARD9 DENND5B ITSN1 BIRC3 HEATR5A SH3PXD2A FCRL5	5.40e-06	171	248	8	23b3120706bb9c20b9214fe3760c6d7a84f1e749
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Neuron\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	TDRD9 PARD6A STARD9 ABTB2 DDX31 FBRSL1 GSN PC	6.40e-06	175	248	8	2812ac2ef41d245db544697fb6da1883361c96e8
ToppCell	PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF185 TMOD4 DAGLA XPNPEP2 GSN HIVEP3 VCAN MACF1	6.67e-06	176	248	8	d30241fb8119834d6e7b59efec3f92fc7a3d1247
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_Peritubular_Capilary_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLXND1 STARD9 ALDH3A1 NOTCH4 VWF F2RL3 SHANK3 LIMS2	7.86e-06	180	248	8	16728b9a1c52097e3a460534be71a476ecc54f0f
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MATN2 PCDH19 NGF DAGLA COL6A3 RTL6 VCAN CHRD	7.86e-06	180	248	8	39ae8586efd91536e9ac6408d26de7e6d6237c41
ToppCell	5'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLXND1 NOTCH4 OTOA VWF F2RL3 CXCL2 SSUH2 GAB3	8.19e-06	181	248	8	7d7d1edeae4e0ebe40b324d1231cd26e27ba9d42
ToppCell	droplet-Kidney-nan-3m-Mesenchymal-podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MATN2 FNDC1 TNC PCDHGA5 GRB14 VCAN MARK4 EGFLAM	8.19e-06	181	248	8	0b1e7335648823b1d83bdfa878ccd44efe7bba9a
ToppCell	tumor_Lymph_Node_/_Brain-Endothelial_cells\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	HTRA1 MATN2 INSR MCF2L NOTCH4 VWF F2RL3 SHANK3	8.53e-06	182	248	8	d7cce5dd7046f06bf40f00c9dbfa610722b03333
ToppCell	COVID-19-Heart-EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NGF MCF2L NOTCH4 AGAP2 VWF SHANK3 LIMS2 EGFLAM	8.53e-06	182	248	8	e67f3234165199085c793915ebb1f9bbd845e933
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ABCA1 PLXND1 TULP2 ITSN1 CXCL2 SH3PXD2A LGI3 VCAN	9.99e-06	186	248	8	f73cb91e74a806858650ae97f543fc779ba4cff8
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ABCA1 PLXND1 TULP2 ITSN1 CXCL2 SH3PXD2A LGI3 VCAN	9.99e-06	186	248	8	8694ca16c9780729f4fba67ba20e35745f1eb4e9
ToppCell	tumor_Lymph_Node_/_Brain-Endothelial_cells-Tumor_ECs\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	HTRA1 MATN2 INSR MCF2L NOTCH4 VWF F2RL3 SHANK3	1.04e-05	187	248	8	be5f8c5802b0fa8cc1e274fdf06b13eb8ceb8ad4
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HTRA1 PTPRE NHS HAP1 IGDCC3 CRH SLC22A3 VCAN	1.08e-05	188	248	8	c66fccdfe68760b8c3efca77e3c25966dc9a8a5f
ToppCell	Ciliated_cells-B-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	CCDC78 DLEC1 ALDH3A1 GRIN3B TMEM231 DNAH10 GPX2 DNAH11	1.08e-05	188	248	8	606907c865bd2f11bb6474932716550f7723d858
ToppCell	Fibroblast-A\|World / shred on cell class and cell subclass (v4)	FGFR4 PDLIM2 COL6A3 GSN HIVEP3 VCAN MACF1 EGFLAM	1.08e-05	188	248	8	6740bed5fb8f45b6eea17041894b804214c2a4ae
ToppCell	5'-Adult-Appendix-Endothelial-blood_vessel_EC-arterial_capillary\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLXND1 MCF2L NOTCH4 MIER2 VWF F2RL3 SHANK3 LIMS2	1.08e-05	188	248	8	a11b12f1857953bcdbfb5f25e127f2350c39567d
ToppCell	facs-Thymus-Epithelium-3m-Mesenchymal\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HTRA1 EFS GFAP COL6A3 IGDCC3 GRB14 CACHD1 TRIM47	1.12e-05	189	248	8	1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55
ToppCell	facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HTRA1 EFS GFAP COL6A3 IGDCC3 GRB14 CACHD1 TRIM47	1.12e-05	189	248	8	14833feea8f80744a06ece73f813eaeff8c4dd61
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLXND1 NOTCH4 VWF F2RL3 CXCL2 SHANK3 GSN SSUH2	1.12e-05	189	248	8	9e58411e51019ca59e78d3e737d65d2bcbbea2be
ToppCell	facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HTRA1 EFS GFAP COL6A3 IGDCC3 GRB14 CACHD1 TRIM47	1.12e-05	189	248	8	bfb1c183a8a2752a2368b74150e66181c6a9da48
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ABCA1 MATN2 NHS RARRES1 WNT2B VCAN EGFLAM HAS1	1.17e-05	190	248	8	0fea33f2dc1efa23aaa2da1c318482a52a313ff1
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HGH1 TOR4A NAGS PARD6A HEATR3 SH3PXD2A FURIN RAVER2	1.17e-05	190	248	8	63018acb7ad80415e861643162abdc2e55968ee4
ToppCell	COVID-19-Heart-EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	NGF NHS MCF2L NOTCH4 AGAP2 VWF SHANK3 EGFLAM	1.17e-05	190	248	8	a21653bfb7bafbc273f94fa7c13bfb48cf8fd562
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	MATN4 GFAP FNDC1 KCNS1 ABTB2 CA9 GSN C2orf72	1.21e-05	191	248	8	273c4a757292a9301de0eaeacdec91c9866be229
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ABCA1 NHS COL6A3 RARRES1 TNC HIVEP3 SH3PXD2A VCAN	1.21e-05	191	248	8	08720998aa55131d7377c4c67c4c935865bd7d79
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HTRA1 EFS FNDC1 PCDH19 NGF ALDH3A1 COL6A3 HAS1	1.21e-05	191	248	8	24dc77ee8de01b42559f92721655f4281b114e17
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLXND1 STARD9 NOTCH4 VWF CACHD1 SHANK3 LIMS2 MARK4	1.26e-05	192	248	8	c0e59e642b42c055cf73d029cf54d07d9b719359
ToppCell	droplet-Bladder-BLADDER-1m-Endothelial-endothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLXND1 FAM181B MCF2L NOTCH4 VWF SHANK3 TRIM47 GRAP	1.31e-05	193	248	8	13731b7fc1e3bec0cebc44bad7e2ecea358bb76a
ToppCell	droplet-Bladder-BLADDER-1m-Endothelial\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLXND1 FAM181B MCF2L NOTCH4 VWF SHANK3 TRIM47 GRAP	1.31e-05	193	248	8	3a5090f81f35026f435f4a250d1e77601a53af15
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	SLC9A9 ABCA1 RCSD1 PLXND1 PTPRE ITSN1 GAB3 SPRED1	1.36e-05	194	248	8	1dce6d4b6ac41f80677e3e4c335a4f383bd76f85
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PLXND1 PTPRE STARD9 NOTCH4 SHANK3 LIMS2 HIVEP3 MARK4	1.36e-05	194	248	8	b490fffc94f005dff9a34ce34d80ca776e3a1387
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	HTRA1 FAM181B HAP1 TNC GRB14 HEATR5A CRH C2orf72	1.36e-05	194	248	8	7c6c0376603e5fcb64814fd6204d153629c2fbf5
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	NRG1 PLXND1 VWF WNT2B CXCL2 SHANK3 GSN SNTB2	1.36e-05	194	248	8	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-J_(Lipofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	PTPRE CA9 RARRES1 BIRC3 CXCL2 BICDL1 HAS1 TRIM47	1.36e-05	194	248	8	784b15119c91ace33d34bfb3d68c182566a3e9a8
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FGFR4 PDLIM2 COL6A3 GSN HIVEP3 VCAN MACF1 EGFLAM	1.41e-05	195	248	8	598b69032a8441a23749b27863d80f7a1fc82a96
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FGFR4 PDLIM2 COL6A3 GSN HIVEP3 VCAN MACF1 EGFLAM	1.41e-05	195	248	8	8aa753934debffe5ae4b5eecb6b50c46d17cc3ec
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	HMCN2 PTPRE NOTCH4 VWF SHANK3 GSN LIMS2 XPR1	1.41e-05	195	248	8	d35102f95bb1e419d2df05ff0a01b6c5c923acef
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLXND1 PTPRE NOTCH4 VWF SHANK3 GSN LIMS2 MARK4	1.46e-05	196	248	8	48b4a9cea97a55190217deaf51bf867608c5a9a7
ToppCell	(5)_Fibroblast-J_(Lipofibroblast)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	MATN2 NGF CA9 COL6A3 RARRES1 EGFLAM HAS1 TRIM47	1.46e-05	196	248	8	afa29399decd17fda7d63add5039ff778627ccc2
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLXND1 PTPRE NOTCH4 VWF SHANK3 GSN LIMS2 MARK4	1.46e-05	196	248	8	473980c827443464d08a0be28c53e3536369b12a
ToppCell	facs-Lung-nan-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA1 HTRA1 MATN2 FNDC1 COL6A3 CACHD1 GSN VCAN	1.46e-05	196	248	8	787c6cd92035e0b1108c2c086c42a229016e476b
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MATN2 PLXND1 HMCN2 NOTCH4 VWF SHANK3 GSN LIMS2	1.46e-05	196	248	8	a20a56d8997d6db2a10046c8801c619a379de83c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLXND1 PTPRE STARD9 NOTCH4 VWF SHANK3 LIMS2 MARK4	1.46e-05	196	248	8	ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PLXND1 PTPRE NOTCH4 VWF SHANK3 GSN LIMS2 MARK4	1.46e-05	196	248	8	8f2031b1a9232c389517fbf3c29f47f9468b0077
ToppCell	facs-Lung-nan\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA1 HTRA1 MATN2 FNDC1 COL6A3 CACHD1 GSN VCAN	1.46e-05	196	248	8	b05f77f3990b662682ffeaf0e4c2fb190e0a6e65
ToppCell	COVID-19-kidney-VWF+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	PLXND1 PTPRE MCF2L NOTCH4 VWF F2RL3 SHANK3 LIMS2	1.46e-05	196	248	8	b71b197cb92117dd9efaa13de000841901cc4ca8
ToppCell	PND07-Mesenchymal\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HTRA1 PDLIM2 COL6A3 TNC GSN VCAN MACF1 EGFLAM	1.46e-05	196	248	8	0050c7134473fbfd7b9f0ae8d6d337713e60b57d
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	INSR PLXND1 NOTCH4 VWF F2RL3 CACHD1 SHANK3 LIMS2	1.46e-05	196	248	8	e224338490691d92c1f70b57112fabdcc92b06a9
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CCDC78 DLEC1 GRIN3B TMEM231 DNAH10 USP43 ARHGAP39 DNAH11	1.51e-05	197	248	8	74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SREBF1 CLCN4 COBL FA2H SIK3 GSN LDB3 LGI3	1.51e-05	197	248	8	82b8e22317cad6d3786bd70d91107007c0ccd7cd
ToppCell	3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PLXND1 NOTCH4 MIER2 VWF F2RL3 SHANK3 GSN LIMS2	1.51e-05	197	248	8	947042f888335c0829d4d5daeb623973eadb3348
ToppCell	367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	HTRA1 CHD3 FNDC1 PDLIM2 COL6A3 TNC SH3PXD2A VCAN	1.57e-05	198	248	8	c55608633f66e3d434c5d81324efb07c5120d2c2
ToppCell	metastatic_Brain-Endothelial_cells\|metastatic_Brain / Location, Cell class and cell subclass	HTRA1 INSR PCDH19 NOTCH4 VWF SHANK3 LIMS2 GRAP	1.57e-05	198	248	8	97ef7946ef11ac93318c1dd46b548dc01e5a6aba
ToppCell	367C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	HTRA1 CHD3 FNDC1 PDLIM2 COL6A3 TNC SH3PXD2A VCAN	1.57e-05	198	248	8	3e5459038fc6ed95f529eb4d1dc5113e16c19012
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATN2 NGF COL6A3 RARRES1 CXCL2 EGFLAM HAS1 TRIM47	1.57e-05	198	248	8	c66097ae9ba0b50561083c423565665958ef0bb8
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PDLIM2 COL6A3 TNC GSN HIVEP3 VCAN MACF1 EGFLAM	1.63e-05	199	248	8	2cec0e370ee9bb3c88a7acb5519e9ea8ddb399bc
ToppCell	ILEUM-inflamed-(8)_Fibroblasts\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MATN2 QSOX1 FNDC1 FGFR4 COL6A3 TNC WNT2B VCAN	1.63e-05	199	248	8	3a3e2bb21cd0293622b1a975263e918d9ba24265
ToppCell	(05)_Secretory-(2)_GFP_FOXI1\|(05)_Secretory / shred by cell type by condition	INSR SIK1 TRIP11 ANKIB1 MAFF GNAS ITSN1 CXCL2	1.63e-05	199	248	8	d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PDLIM2 COL6A3 TNC GSN HIVEP3 VCAN MACF1 EGFLAM	1.63e-05	199	248	8	9e87b64e16d595701c3beb07aa835afe3330bd10
ToppCell	Kidney-Endothelial\|Kidney / Skin and Kidney Cells in Lupus Nephritis Patients.	PLXND1 NOTCH4 MIER2 VWF F2RL3 SHANK3 GSN LIMS2	1.63e-05	199	248	8	b543f0686522df43737e9ffa5c9733e42b8a9f4d
ToppCell	tumor_Lung-Myeloid_cells-mo-Mac\|Myeloid_cells / Location, Cell class and cell subclass	ABCA1 RNF13 PLXND1 GLMP OTOA RARRES1 CXCL2 SPRED1	1.69e-05	200	248	8	58ff8db0ecf71daa86f9a38208e0d9b712cac0b5
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATN2 NGF COL6A3 RARRES1 XPNPEP2 EGFLAM HAS1 TRIM47	1.69e-05	200	248	8	d64895354218ebd0217011bae0967a6883bbd1cd
ToppCell	LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TDRD9 EML6 CCDC78 DLEC1 ALDH3A1 TMEM231 DNAH10 SOX30	1.69e-05	200	248	8	96701a4d57753f5ec0dd5c7550054bbcc946bc5f
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PLXND1 HMCN2 NOTCH4 VWF SHANK3 GSN SSUH2 LIMS2	1.69e-05	200	248	8	93e13937ec74418a697c37d56f57509fb2154780
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm\|5w / Sample Type, Dataset, Time_group, and Cell type.	PARD6A CA9 ARMC12 SIK3 ANKZF1 BICDL1 HELZ2 CHRD	1.69e-05	200	248	8	0927061536a664b4f7feb9e5b0a8c11ca0d5955c
ToppCell	E18.5-samps-Mesenchymal-Pericyte-pericyte_B\|E18.5-samps / Age Group, Lineage, Cell class and subclass	SLC9A9 SSTR4 TULP2 STARD9 PCDHGA11 FA2H XPNPEP2	2.23e-05	151	248	7	8ba15ab24fe2e71df0a2a7511ca451ad2376bd91
ToppCell	PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TOR4A CHD3 ABCC10 MIER2 GPLD1 SLC25A12 TRAV19	2.43e-05	153	248	7	5ac4b97d35c1029a5fc625239f92e35136c4d832
ToppCell	COVID-19-APC-like-Monocytes\|COVID-19 / group, cell type (main and fine annotations)	EML6 DHODH GPX2 RIN1 RPAP1 TJAP1 RSBN1L	2.99e-05	158	248	7	a0d94bd067424783863a48db20976d4c2043600c
ToppCell	P07-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FGFR4 PDLIM2 COL6A3 GSN HIVEP3 VCAN MACF1	3.37e-05	161	248	7	b19f82dd98a3064581793711bb70373f18abecd9
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ABCA1 HTRA1 PTPRE FGF8 MAFF CXCL2 VCAN	3.37e-05	161	248	7	4362fe0c151f49eae7372b9673bac64d980a8389
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P2\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	EFS ABTB2 PCDHGB7 LIMS2 VCAN DNAH11	3.50e-05	110	248	6	ee45592e936d32881c0f3429c21360670e5b3ce3
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	EFS ABTB2 PCDHGB7 LIMS2 VCAN DNAH11	3.50e-05	110	248	6	b9c8014fd2820e5ea28a7e02fd24227b99e71eb3
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ABCA1 HTRA1 PTPRE FGF8 MAFF CXCL2 VCAN	3.79e-05	164	248	7	10741c7706a37b24aa08a300b27d60d6b8600167
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ABCA1 HTRA1 PTPRE FGF8 MAFF CXCL2 VCAN	3.79e-05	164	248	7	7077683afee91828ad2b95e0f81c2b27aae0f831
ToppCell	normal_Lung-Fibroblasts-Myofibroblasts\|Fibroblasts / Location, Cell class and cell subclass	FNDC1 HMCN2 COL6A3 TNC SH3PXD2A VCAN FAM87A	3.79e-05	164	248	7	9b4a6007abae992db871d9f6f731d5af724de30d
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HMCN2 NOTCH4 VWF WNT2B SHANK3 SSUH2 LIMS2	3.94e-05	165	248	7	a74751e0ec857aa974bec04ccc747c004a8f6e01
Drug	Fluticasone propionate [80474-14-2]; Up 200; 8uM; MCF7; HT_HG-U133A	SIK1 PLXND1 SSTR4 MAFF FGFR4 TMEM231 GPLD1 CALCR TNC RIN1 TJAP1 HAS1 MAST3	1.45e-07	192	241	13	4129_UP
Drug	AC1MBZ1C	NRG1 SRC SIK1 TYK2 EEF2K PLCB3 GNAS CACNA1A GPLD1 CALCR CXCL2 CRH P2RY6 SLC18A3 CSNK1E ATP2B1	4.12e-06	387	241	16	CID000003541
Drug	Clomipramine hydrochloride [17321-77-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A	RALGAPA1 BRAF MOCS3 FGFR4 PLPPR2 HEATR3 CDC14A RIN1 CSNK1E MARK4 PC	7.85e-06	195	241	11	6825_DN
Drug	Piroxicam [36322-90-4]; Down 200; 12uM; PC3; HT_HG-U133A	TOR4A CHD3 CLCN4 PLCB3 LMF1 FA2H XRCC1 ANKZF1 RIN1 CSNK1E PC	8.24e-06	196	241	11	2089_DN
Drug	Vincamine [1617-90-9]; Up 200; 11.2uM; HL60; HT_HG-U133A	TRO CLCN4 KCNS1 TMEM231 DAGLA PLPPR2 TRAPPC9 GPLD1 SCLY VCAN MARK4	9.51e-06	199	241	11	2367_UP
Drug	Ketotifen fumarate [34580-14-8]; Down 200; 9.4uM; PC3; HT_HG-U133A	CHD3 BRAF COBL MAFF BOLA1 ANKZF1 HIVEP3 RIN1 VCAN MARK4 MAST3	9.98e-06	200	241	11	5842_DN
Drug	STOCK1N-35215; Up 200; 10uM; PC3; HT_HG-U133A	GLB1L SIK1 PTPRE MAFF CACNA1A POLG POM121L2 CXCL2 CDC14A CSNK1E	2.56e-05	182	241	10	6427_UP
Drug	Dobutamine hydrochloride [49745-95-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	RALGAPA1 PLXND1 MOCS3 PLCB3 MAFF CALCR TNC CXCL2 CSNK1E VCAN	2.94e-05	185	241	10	6286_UP
Drug	N6-Me-dAdo	GFAP NGF CACNA1A P2RY6	4.19e-05	19	241	4	CID000168948
Drug	ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A	GLB1L MOCS3 DHODH COBL TMEM231 GPLD1 LMF1 POLG RIN1 VCAN	4.60e-05	195	241	10	7539_DN
Drug	Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; PC3; HT_HG-U133A	TOR4A CHD3 ACOX3 NFATC3 PLCB3 ITSN1 SCLY CSNK1E GLCE MAST3	4.80e-05	196	241	10	2119_DN
Drug	Amyleine hydrochloride [532-59-2]; Up 200; 14.8uM; PC3; HG-U133A	SREBF1 CHD3 SSTR4 LRFN4 NFATC3 DAGLA DDX31 POM121L2 HIVEP3 RNF123	5.01e-05	197	241	10	1909_UP
Drug	Epirizole [18694-40-1]; Down 200; 17uM; PC3; HT_HG-U133A	PARD6A MAFF LMF1 SPOUT1 FA2H FAAP100 CDC14A RIN1 MARK4 PC	5.01e-05	197	241	10	1803_DN
Drug	Bendroflumethiazide [73-48-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A	SRC PSMB2 SIK1 CHD3 NFATC3 ABTB2 TRAPPC11 P2RY6 FURIN PANK4	5.01e-05	197	241	10	3415_DN
Drug	Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A	MAB21L4 FGFR4 MCF2L PLPPR2 DDX31 CDC14A RPAP1 CSNK1E PC MAST3	5.01e-05	197	241	10	3308_DN
Drug	4-ethylsulfonylnaphthalene-1-sulfonamide	INSR GFAP PARD6A GNAS TRAPPC9 NTF4 SLC18A3 CHRD	5.08e-05	123	241	8	CID000013296
Drug	Articaine hydrochloride [23964-57-0]; Down 200; 12.4uM; PC3; HT_HG-U133A	INSR TOR4A TRIP11 FGFR4 TMEM231 ABTB2 POLG BIRC3 RIN1 MARK4	5.23e-05	198	241	10	7272_DN
Drug	Ethionamide [536-33-4]; Up 200; 24uM; HL60; HT_HG-U133A	RALGAPA1 TRO ZNF185 TULP2 AGAP2 GPLD1 LMF1 TNC CDC14A GSN	5.23e-05	198	241	10	2495_UP
Drug	Aspartic acid, N-acetyl (R,S) [997-55-7]; Up 200; 22.8uM; PC3; HT_HG-U133A	CLCN4 NFATC3 DHODH COBL KCNS1 HAP1 CDC14A RIN1 P2RY6 TJAP1	5.23e-05	198	241	10	4007_UP
Drug	Oxybenzone [131-57-7]; Down 200; 17.6uM; HL60; HT_HG-U133A	SRC ZNF696 TRIP11 CLCN4 KCNS1 POLG FAAP100 CDC14A RPAP1 SNTB2	5.23e-05	198	241	10	3092_DN
Drug	Phensuximide [86-34-0]; Up 200; 21.2uM; HL60; HT_HG-U133A	BRAF TMEM231 AGAP2 DDX31 POLG BIRC3 XPNPEP2 FAAP100 CDC14A P2RY6	5.23e-05	198	241	10	2960_UP
Drug	Isoxsuprine hydrochloride [579-56-6]; Up 200; 11.8uM; HL60; HG-U133A	EFS ZNF696 CHD3 KCNS1 GNAS CA9 ITSN1 HIVEP3 FURIN TJAP1	5.23e-05	198	241	10	1985_UP
Drug	Deptropine citrate [2169-75-7]; Up 200; 7.6uM; MCF7; HT_HG-U133A	RALGAPA1 CLCN4 MAFF PLPPR2 CA9 HAP1 POLG POM121L2 GSN MARK4	5.46e-05	199	241	10	5543_UP
Drug	Cortisone [53-06-5]; Up 200; 11uM; MCF7; HT_HG-U133A	SRC INSR TRIP11 FGFR4 LMF1 ITSN1 ANKZF1 GSN BICDL1 SLC25A12	5.46e-05	199	241	10	7416_UP
Drug	Oxethazaine [126-27-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A	MYO9A CHD3 FGFR4 PLPPR2 ABTB2 TRAPPC9 TRAPPC11 ITSN1 ANKZF1 SLC25A12	5.46e-05	199	241	10	1484_DN
Drug	Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; PC3; HT_HG-U133A	SRC TOR4A CHD3 CLCN4 DHODH TMEM231 LMF1 CSNK1E VCAN TJAP1	5.46e-05	199	241	10	4649_DN
Drug	E 14	GFAP FGF8 CACNA1A TNC VCAN	5.47e-05	39	241	5	CID000122591
Drug	Isosorbide dinitrate [87-33-2]; Up 200; 17uM; MCF7; HT_HG-U133A	ABCA1 EFS TRO SRC INSR POM121L2 CRH C2orf72 MARK4 TJAP1	5.69e-05	200	241	10	6038_UP
Drug	Terazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; PC3; HT_HG-U133A	BRAF COBL LMF1 POLG ANKZF1 GSN RIN1 RNF123 CSNK1E VCAN	5.69e-05	200	241	10	5831_DN
Disease	childhood trauma measurement, alcohol consumption measurement	PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5	2.23e-05	71	235	6	EFO_0007878, EFO_0007979
Disease	autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology)	STRC STRCP1	6.32e-05	2	235	2	DOID:0110471 (implicated_via_orthology)
Disease	Ischemic stroke	NRG1 TMOD4 CHD3 TRAPPC11 COL6A3 WNT2B SH3PXD2A FURIN FCRL5 ATP2B1 DNAH11	6.37e-05	324	235	11	HP_0002140
Disease	Seizures	RNF13 GFAP TMEM70 NGF FA2H POLG CRH MACF1 ATP1A1	6.79e-05	218	235	9	C0036572
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	ABCA1 INSR PLCB3 MAFF LMF1 DNAH10 E2F3 SLC22A3 MACF1	8.36e-05	224	235	9	EFO_0004530, EFO_0008317
Disease	gluteofemoral adipose tissue measurement	ABCA1 FASTKD5 PLXND1 PLCB3 MAFF DNAH10 SLC22A3	9.42e-05	132	235	7	EFO_0803317
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	ABCA1 FFAR4 PLCB3 MAFF DNAH10 GRB14 SIK3 HELZ2 MACF1 IRGC	1.24e-04	291	235	10	EFO_0008317, EFO_0020946
Disease	central nervous system cancer, glioblastoma multiforme	HEATR3 LMF1 RAVER2	1.70e-04	14	235	3	EFO_0000326, EFO_0000519
Disease	Cafe-au-Lait Spots	GNAS SPRED1	1.88e-04	3	235	2	C0221263
Disease	Neurofibrosarcoma	HTRA1 SH3PXD2A	1.88e-04	3	235	2	C0206729
Disease	Grand Mal Status Epilepticus	SRC SSTR4 NGF CCR10 CRH	1.98e-04	67	235	5	C0311335
Disease	phospholipids:total lipids ratio, intermediate density lipoprotein measurement	ABCA1 DHODH LMF1 SIK3 MACF1	1.98e-04	67	235	5	EFO_0008595, EFO_0020946
Disease	Petit mal status	SRC SSTR4 NGF CCR10 CRH	1.98e-04	67	235	5	C0270823
Disease	Complex Partial Status Epilepticus	SRC SSTR4 NGF CCR10 CRH	1.98e-04	67	235	5	C0393734
Disease	Status Epilepticus, Subclinical	SRC SSTR4 NGF CCR10 CRH	1.98e-04	67	235	5	C0751522
Disease	Simple Partial Status Epilepticus	SRC SSTR4 NGF CCR10 CRH	1.98e-04	67	235	5	C0751524
Disease	Non-Convulsive Status Epilepticus	SRC SSTR4 NGF CCR10 CRH	1.98e-04	67	235	5	C0751523
Disease	Status Epilepticus	SRC SSTR4 NGF CCR10 CRH	2.13e-04	68	235	5	C0038220
Disease	diabetic neuropathy (biomarker_via_orthology)	NRG1 SREBF1 NGF	3.12e-04	17	235	3	DOID:9743 (biomarker_via_orthology)
Disease	trait in response to apixaban	TRO FFAR4 GNAS MIER2 ARMC12 CSNK1E	3.27e-04	115	235	6	OBA_2050328
Disease	von Willebrand's disease 1 (is_implicated_in)	ITGA2B VWF	3.75e-04	4	235	2	DOID:0060573 (is_implicated_in)
Disease	Malignant Peripheral Nerve Sheath Tumor	HTRA1 SH3PXD2A	3.75e-04	4	235	2	C0751690
Disease	DiGeorge syndrome (implicated_via_orthology)	PLXND1 FGF8 CHRD	4.40e-04	19	235	3	DOID:11198 (implicated_via_orthology)
Disease	polycystic kidney disease (biomarker_via_orthology)	GNAS GPBAR1 TNC	4.40e-04	19	235	3	DOID:0080322 (biomarker_via_orthology)
Disease	esophagus squamous cell carcinoma (is_implicated_in)	HTRA1 FGFR4 XRCC1 KMT2D	4.52e-04	45	235	4	DOID:3748 (is_implicated_in)
Disease	Colorectal Carcinoma	ABCA1 EFS SF3A1 SRC MCF2L2 BRAF GNAS DNAH8 PLPPR2 TBX22 XRCC1 CDC14A HIVEP3 RPAP1 PANK4	5.51e-04	702	235	15	C0009402
Disease	squamous cell lung carcinoma, family history of lung cancer	COBL TLX3 SLC22A3 LRP11 PC	6.00e-04	85	235	5	EFO_0000708, EFO_0006953
Disease	endodermal sinus tumor (is_marker_for)	FGF8 WNT2B	6.22e-04	5	235	2	DOID:1911 (is_marker_for)
Disease	syntactic complexity measurement, specific language impairment	HAP1 TNC	6.22e-04	5	235	2	EFO_0007799, EFO_1001510
Disease	Lewy Body Disease	INSR GFAP NGF	6.87e-04	22	235	3	C0752347
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	ABCA1 INSR FFAR4 PLCB3 SIK3 SLC22A3 MACF1 IRGC	6.98e-04	239	235	8	EFO_0008317, EFO_0020945
Disease	hepatocellular carcinoma (is_marker_for)	NRG1 ABCA1 HTRA1 SRC INSR FGFR4 CA9 SOX30 BIRC3	7.36e-04	301	235	9	DOID:684 (is_marker_for)
Disease	Sarcosine measurement	PCDHGB3 PCDHGB2 PCDHGA5	7.85e-04	23	235	3	EFO_0021668
Disease	hypertension	INSR EML6 TMOD4 PLCB3 COL6A3 WNT2B FBRSL1 FURIN ATP2B1	8.46e-04	307	235	9	EFO_0000537
Disease	lung non-small cell carcinoma (is_implicated_in)	FGFR4 CA9 BIRC3 E2F3 XRCC1 KMT2D	8.91e-04	139	235	6	DOID:3908 (is_implicated_in)
Disease	mental development measurement	PCDHGB3 PCDHGB2 PCDHGA5	1.01e-03	25	235	3	EFO_0008230
Disease	Alzheimer's disease (is_marker_for)	NRG1 INSR EEF2K GNAS CRH AIFM1 SLC18A3 CSNK1E	1.11e-03	257	235	8	DOID:10652 (is_marker_for)
Disease	Sezary Syndrome	CHD3 BRAF KMT2D	1.27e-03	27	235	3	C0036920
Disease	ductal carcinoma in situ (is_implicated_in)	SRC NOTCH4	1.29e-03	7	235	2	DOID:0060074 (is_implicated_in)
Disease	familial hemiplegic migraine (implicated_via_orthology)	CACNA1A ATP1A1	1.29e-03	7	235	2	DOID:0060178 (implicated_via_orthology)
Disease	tumor necrosis factor ligand superfamily member 6, soluble form measurement	RNF123 CELSR3	1.29e-03	7	235	2	EFO_0020797
Disease	mean platelet volume	SLC9A9 EML6 PLXND1 ITGA2B KCNS1 GNAS MCF2L VWF PCDHGC4 PCDHGB7 PCDHGB3 PCDHGB2 PCDHGA11 PCDHGA5 FBRSL1 SIK3 SHANK3 MARK4	1.45e-03	1020	235	18	EFO_0004584
Disease	central nervous system cancer, glioma	HEATR3 LMF1 RAVER2	1.56e-03	29	235	3	EFO_0000326, EFO_0005543
Disease	Bipolar Disorder	NRG1 GFAP STARD9 DNAH8 NOTCH4 CACNA1A POLG CRH CSNK1E ATP1A1 PC	1.65e-03	477	235	11	C0005586
Disease	Colon Carcinoma	SRC BRAF	2.19e-03	9	235	2	C0699790
Disease	Autosomal Recessive Polycystic Kidney Disease	SRC IFT88	2.19e-03	9	235	2	C0085548
Disease	interferon alpha/beta receptor 1 measurement	TYK2 ITSN1	2.19e-03	9	235	2	EFO_0021850
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	ABCA1 FFAR4 PLCB3 SLC22A3 HELZ2 MACF1 IRGC	2.26e-03	225	235	7	EFO_0008317, EFO_0020947
Disease	joint hypermobility measurement	FNDC1 NOTCH4 VCAN	2.28e-03	33	235	3	EFO_0007905
Disease	Prescription Drug Abuse	INSR QSOX1 DNAH8 RTL6 SLC22A3	2.32e-03	115	235	5	C4316881
Disease	Substance-Related Disorders	INSR QSOX1 DNAH8 RTL6 SLC22A3	2.32e-03	115	235	5	C0236969
Disease	Organic Mental Disorders, Substance-Induced	INSR QSOX1 DNAH8 RTL6 SLC22A3	2.32e-03	115	235	5	C0029231
Disease	Drug habituation	INSR QSOX1 DNAH8 RTL6 SLC22A3	2.32e-03	115	235	5	C0013170
Disease	Drug abuse	INSR QSOX1 DNAH8 RTL6 SLC22A3	2.32e-03	115	235	5	C0013146
Disease	Drug Use Disorders	INSR QSOX1 DNAH8 RTL6 SLC22A3	2.32e-03	115	235	5	C0013222
Disease	Drug Dependence	INSR QSOX1 DNAH8 RTL6 SLC22A3	2.32e-03	115	235	5	C1510472
Disease	Substance Dependence	INSR QSOX1 DNAH8 RTL6 SLC22A3	2.32e-03	115	235	5	C0038580
Disease	Substance Use Disorders	INSR QSOX1 DNAH8 RTL6 SLC22A3	2.32e-03	115	235	5	C0038586
Disease	mean arterial pressure	INSR EML6 SIK1 NGF GNAS ABCC10 WNT2B HIVEP3 FURIN MARK4 ATP2B1	2.34e-03	499	235	11	EFO_0006340
Disease	Substance abuse problem	INSR QSOX1 DNAH8 RTL6 SLC22A3	2.41e-03	116	235	5	C0740858
Disease	radius bone mineral density	SLC9A9 CACNA1A SSUH2	2.49e-03	34	235	3	EFO_0007933
Disease	chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	SIK3 SLC22A3 MAST3	2.49e-03	34	235	3	EFO_0008317, EFO_0008596, EFO_0020947
Disease	squamous cell carcinoma, esophageal carcinoma	HEATR3 HAP1	2.72e-03	10	235	2	EFO_0000707, EFO_0002916
Disease	creativity measurement	NRG1 MAIP1	2.72e-03	10	235	2	EFO_0010650
Disease	thyroid gland papillary carcinoma (is_implicated_in)	BRAF KMT2D	2.72e-03	10	235	2	DOID:3969 (is_implicated_in)
Disease	sleep duration, high density lipoprotein cholesterol measurement	ABCA1 COBL GRB14 MACF1 SPRED1	2.89e-03	121	235	5	EFO_0004612, EFO_0005271
Disease	lung squamous cell carcinoma (is_marker_for)	SRC SOX30 E2F3	2.93e-03	36	235	3	DOID:3907 (is_marker_for)
Disease	response to sulfasalazine, Drug-induced agranulocytosis	GNAS MROH6 IFT88	3.17e-03	37	235	3	EFO_0008324, HP_0012235
Disease	Paranoia	TYK2 DNAH8	3.31e-03	11	235	2	C1456784
Disease	invasive ductal carcinoma (is_implicated_in)	XRCC1 CSNK1E	3.31e-03	11	235	2	DOID:3008 (is_implicated_in)
Disease	phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement	ABCA1 INSR FFAR4 DHODH PLCB3 SIK3 MACF1 DNAH11	3.36e-03	307	235	8	EFO_0004612, EFO_0020946
Disease	coronary artery calcification	NRG1 ABCA1 SF3A1 COQ2 STARD9 ERI3 ZNRF2 EYS IFT88 EGFLAM	3.45e-03	450	235	10	EFO_0004723
Disease	Manic	STARD9 DNAH8 SHANK3 PC	3.53e-03	78	235	4	C0338831
Disease	systolic blood pressure, alcohol drinking	INSR ABCC10 EYS FURIN ATP2B1	3.67e-03	128	235	5	EFO_0004329, EFO_0006335
Disease	Cardiomyopathies	BRAF TMEM70 POLG LIMS2 LDB3	3.93e-03	130	235	5	C0878544
Disease	hyperhomocysteinemia (biomarker_via_orthology)	NGF ATP1A1	3.95e-03	12	235	2	DOID:9279 (biomarker_via_orthology)
Disease	dementia (is_implicated_in)	NRG1 NOTCH4	3.95e-03	12	235	2	DOID:1307 (is_implicated_in)
Disease	amyloid plaque accumulation rate	MOCS3 UBR3	3.95e-03	12	235	2	EFO_0007646
Disease	triacylglycerol 58:12 measurement	MATN2 E2F3	3.95e-03	12	235	2	EFO_0010439
Disease	intracranial aneurysm (is_implicated_in)	KMT2D VCAN	3.95e-03	12	235	2	DOID:10941 (is_implicated_in)
Disease	Nonsyndromic Deafness	STRC OTOA TNC CDC14A	4.04e-03	81	235	4	C3711374
Disease	colon carcinoma (is_marker_for)	SRC KMT2D	4.65e-03	13	235	2	DOID:1520 (is_marker_for)
Disease	salicylurate measurement	LMF1 CHTF18	4.65e-03	13	235	2	EFO_0010532
Disease	retinitis pigmentosa (biomarker_via_orthology)	NGF AIFM1	4.65e-03	13	235	2	DOID:10584 (biomarker_via_orthology)
Disease	lung adenocarcinoma (is_marker_for)	SRC EEF2K SOX30 E2F3	4.80e-03	85	235	4	DOID:3910 (is_marker_for)
Disease	response to methotrexate, serum alanine aminotransferase measurement	TRAPPC9 CACHD1 RAVER2	4.87e-03	43	235	3	EFO_0004735, GO_0031427
Disease	triglycerides in large LDL measurement	ABCA1 SIK3 SLC22A3	4.87e-03	43	235	3	EFO_0022319
Disease	very low density lipoprotein cholesterol measurement	ABCA1 INSR PLCB3 DNAH10 SIK3 SLC22A3 DNAH11	5.00e-03	260	235	7	EFO_0008317
Disease	Schizophrenia	NRG1 ABCA1 SREBF1 FASTKD5 GFAP CLVS2 ALDH3A1 GNAS NOTCH4 XRCC1 SHANK3 CRH GSN SH3PXD2A CSNK1E	5.02e-03	883	235	15	C0036341
Disease	high grade glioma (implicated_via_orthology)	INSR BRAF FGFR4	5.19e-03	44	235	3	DOID:3070 (implicated_via_orthology)
Disease	orotic acid measurement	ABTB2 DNAH11	5.40e-03	14	235	2	EFO_0010516
Disease	Impaired cognition	HTRA1 FA2H	5.40e-03	14	235	2	C0338656
Disease	very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio	ABCA1 FFAR4 PLCB3 DNAH10 E2F3 HELZ2 MACF1	5.43e-03	264	235	7	EFO_0008317, EFO_0020944
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	PLCB3 MAFF DNAH10 SIK3 MACF1 IRGC	5.49e-03	200	235	6	EFO_0004611, EFO_0020945
Disease	Malignant neoplasm of breast	NRG1 SRC MCF2L2 BRAF NHS DLEC1 NOTCH4 AGAP2 VWF SMARCAL1 GPX2 SIK3 CXCL2 GSN KMT2D MACF1 FCRL5	5.81e-03	1074	235	17	C0006142
Disease	hip circumference	RALGAPA1 PLXND1 BRAF PLPPR2 NOTCH4 CALCR DNAH10 POM121L2	5.95e-03	338	235	8	EFO_0005093
Disease	stroke	HTRA1 CHD3 WNT2B SH3PXD2A FURIN	6.03e-03	144	235	5	EFO_0000712
Disease	obesity (is_implicated_in)	ABCA1 FFAR4 GNAS CRH	6.10e-03	91	235	4	DOID:9970 (is_implicated_in)
Disease	brain edema (biomarker_via_orthology)	GFAP CXCL2	6.19e-03	15	235	2	DOID:4724 (biomarker_via_orthology)
Disease	RASopathy	BRAF SPRED1	6.19e-03	15	235	2	cv:C5555857

Protein segments in the cluster

Peptide	Gene	Start	Entry
QLDVRPRGAAASLAD	CHRNA10	181	Q9GZZ6
QLADIASVGSPFARA	CACNA1A	441	O00555
SASPAAGLGIFEVRR	ERI3	56	O43414
AADVGLTRASPAARN	CHTF18	151	Q8WVB6
RFLVQSAERPGASLG	FBRSL1	416	Q9HCM7
RSASEPSLNRAGFQT	BRAF	726	P15056
FITAASAARNPSPIR	AADAT	6	Q8N5Z0
APARAAAFLAVLVAS	B3GALT6	51	Q96L58
AAFLAVLVASAPRAA	B3GALT6	56	Q96L58
RAFQPSVSLTVAALG	CCR10	41	P46092
RPNSDFISLGLRDGA	EGFLAM	886	Q63HQ2
AAEARRGQFESVAPS	VCAN	1426	P13611
AAGAAAAAARAIRSP	C2orf72	91	A6NCS6
ALRFSATRRQFGPTE	ACOX3	326	O15254
TAAFAAARSIRARDP	AIFM1	141	O95831
PSNRSARAAAAAAEA	CALCR	421	P30988
DGSTPSDNIVRRFLN	CDC14A	251	Q9UNH5
ARAAFSSGRTRPLQF	ALDH3A1	11	P30838
AQDPSQLSFRRGDII	GRAP	171	Q13588
RFPLARQFSLESGSS	FGFR4	411	P22455
ALERFGENRFVSPLS	ABCA1	1831	O95477
STTVNSRAFNPGRDL	CACHD1	156	Q5VU97
SRAFNPGRDLNSVLA	CACHD1	161	Q5VU97
ASPSVAQLAGRFREQ	RCSD1	16	Q6JBY9
FAASGRLAASQEIPR	DNAH11	106	Q96DT5
AGVPVSERSLARAGF	BIRC3	41	Q13489
RQEFLASVARGVAPA	ANKIB1	721	Q9P2G1
ASSPRVVGDARARAL	AGAP2	521	Q99490
AIQFPRRSSSGFRVD	GLCE	36	O94923
QGTIRPAANFDAIRD	ANXA7	176	P20073
AAFTLRSINPFGNSR	CLCN4	301	P51793
LEENRSFAPALTEGR	DNHD1	3571	Q96M86
AVVSSRFEGLSPLQR	BOLA1	71	Q9Y3E2
GDAVRSPAAAAALIF	BICDL1	31	Q6ZP65
LSGNPADLERREAVF	ATP2B1	71	P20020
VLVFAERLSEGRNAP	ARMC12	251	Q5T9G4
RATQPLNGRVIEASF	CA9	376	Q16790
ASPVAGSLALALRQF	C17orf113	381	A0A1B0GUU1
APGRSTLAALIAAQR	RAVER2	311	Q9HCJ3
GPNTSLAALAREFDR	RBM15B	426	Q8NDT2
AFRESAGAPANRSRR	NTF4	66	P34130
ILDFPAAGSAARRDV	QSOX1	541	O00391
ARGAAEPFLAQARLA	ARHGAP39	546	Q9C0H5
FAAIGPTTARALAAQ	UROS	221	P10746
AAAGTRLVLPFARDA	PCDHGA5	146	Q9Y5G8
FAVNPRSGSLITAGR	PCDHGA11	76	Q9Y5H2
ATPAFRLADSRTNPA	NRG1	601	Q02297
IALRLRQSFSPTAGD	PCDHGB7	711	Q9Y5F8
AREAGFALDPRQASA	PCDH19	46	Q8TAB3
EVSLFDLRRQPGFNS	OTOA	531	Q7RTW8
ASAFPRARRQGVSVL	FHDC1	631	Q9C0D6
RVEGFASQPEAALRI	MAB21L4	361	Q08AI8
FNATPTGRILNRFSS	ABCC10	1016	Q5T3U5
PRGRQLSLSAAAVVD	COQ2	51	Q96H96
GFSLPLARALRGNET	PTPRE	11	P23469
LLTAVFQVPSAAGRR	OR11H4	231	Q8NGC9
GLLSEGQASRPAAAR	IGDCC3	791	Q8IVU1
RFSPAERIVNSNGEL	LIMS2	21	Q7Z4I7
LAAGASFLRAPAAVR	LRP11	111	Q86VZ4
LSRAPDGAALATARA	LRP11	186	Q86VZ4
DGAALATARASPRQE	LRP11	191	Q86VZ4
IAFSEAEGARPLREN	MATN2	146	O00339
SFSEAQGARPRALNV	MATN4	476	O95460
GFARSVAAARGPATL	MAFF	116	Q9ULX9
AALFPRSARALAASA	MAIP1	51	Q8WWC4
RSARALAASALPAQG	MAIP1	56	Q8WWC4
SSSRFLNFGIRDPAQ	EYS	1346	Q5T1H1
LARGTVQRAERFPAS	LDB3	531	O75112
ARSAPAAAIAARVAG	NGF	51	P01138
LTIEALPFQAARASG	NRAP	1286	Q86VF7
PAVGAAAFLSVRVLA	GPBAR1	176	Q8TDU6
LSPERNGINSARFFA	GAB3	481	Q8WWW8
ARLTAFSEVGVPANR	HMCN2	4981	Q8NDA2
ARAAEILARDGPNAL	ATP1A1	66	P05023
ATAGFQARALRPRTS	MCF2L2	1096	Q86YR7
ARAAGDAPLRSLEQA	FFAR4	6	Q5NUL3
AARAGALEIQRRFPS	PLXND1	41	Q9Y4D7
FRAPGLTSVAVASVN	PLXND1	466	Q9Y4D7
LTFRAPRAQAVVGDL	FCRL5	661	Q96RD9
SFQRVIPEDGAAARA	OGDHL	866	Q9ULD0
RFQRANALPASGELD	MMP21	91	Q8N119
RAFELTLQARDQGSP	PCDHGB2	526	Q9Y5G2
AAQEEFRPAATRGSI	DNAH8	3676	Q96JB1
RRNRVSFLGAATVEP	HERVK_113	6	P63132
EASNAGGAARVPFRL	LRRC24	346	Q50LG9
GGAARVPFRLLVNAS	LRRC24	351	Q50LG9
FPGTRLGRLQAAASE	KCNS1	71	Q96KK3
ILATATDAQGFLPAR	LCN10	46	Q6JVE6
PSGRSLVQRDIQAFL	NAGS	96	Q8N159
RSNAALFQLGSAPAV	NLRP2	386	Q9NX02
VFADSPFQRRSVAGR	MROH6	696	A6NGR9
RRGAAAAPLLVAVAA	INSR	6	P06213
APRREASQAAAAASL	FAM181B	146	A6NEQ2
LPTRVDFSLAGALNA	GFAP	46	P14136
RAFELTLQARDQGSP	PCDHGB3	526	Q9Y5G1
FRNQFSLVTAGPLDR	PCDHGC4	401	Q9Y5F7
LDSPAALAERGARNA	CRH	126	P06850
SFGLRDAPRNLSALT	DDX31	746	Q9H8H2
VRARALSSIQGVAPD	FAAP100	746	Q0VG06
ATRTQRPSGFREAAV	IRGC	176	Q6NXR0
RCASPRSLAGVAFSQ	LRIT1	231	Q9P2V4
SPAEASGLRAQDRIV	SLC9A3R1	186	O14745
SEAEQTLRFRGALPD	MACF1	6786	Q9UPN3
RLLNSRFPIEGAADA	PCDHA1	146	Q9Y5I3
LGPAQRARSGTFDLL	PANK4	396	Q9NVE7
CAGSPSLVAAARRAF	PLPPR2	191	Q96GM1
RDFIARDLGPTLANS	GBA	296	P04062
VRAGLFQRSPGDTVA	F2RL3	351	Q96RI0
LPRASVSGFQEFSRL	PARD6A	31	Q9NPB6
SSRNLVTLRVDPNGF	PLCB3	36	Q01970
FSPSEVQRRLAAGAC	FA2H	11	Q7L5A8
LASLFRAGREPQGVS	FGF8	36	P55075
RVLSNGVQFSRISPD	GALM	121	Q96C23
RLTARSQAAAAAAAP	FOXO3B	36	A0A2Z4LIS9
PSLAVRETAAGALRN	HEATR3	91	Q7Z4Q2
DFALSPGFVRLAQER	FASTKD5	491	Q7L8L6
AALRGSAFDPLSQSR	IFT88	106	Q13099
ANVGAALRPAFTSET	HEATR5A	1316	Q86XA9
LAAPASAQLSRAGRS	HTRA1	16	Q92743
SAQLSRAGRSAPLAA	HTRA1	21	Q92743
VAASRRAAGAPLATE	CXCL2	26	P19875
RALLASPGFAAAAAA	E2F3	36	O00716
AAERRLAAQLGAPTS	ANKZF1	661	Q9H8Y5
TGALRQEAIDRFNAP	CHD3	1111	Q12873
IFRAEASTGQDAPRQ	C19orf44	396	Q9H6X5
AEATAQTLRARPASG	FNDC1	801	Q4ZHG4
EQGPLRLIRSASFFA	FNIP1	221	Q8TF40
PARLAEEAFFRGVSQ	FURIN	266	P09958
QLRQRSAFTPATATG	ITSN1	886	Q15811
AKAGARRPSAFSAIQ	HAP1	76	P54257
RRPSAFSAIQGDVRS	HAP1	81	P54257
EPLQAAASALGAAVR	F8A1;	116	P23610
RFGRLLPSFVSSENA	COL6A3	2811	P12111
GVASRRDSLAPLQAE	COBL	571	O75128
LLPQADTRSFVVDRG	GLB1L	21	Q6UWU2
LAGENFDQSPLRRTF	DENND5B	41	Q6ZUT9
AGQAPATTALRTFLE	CCDC78	261	A2IDD5
ASAPLRAQVRAAGTA	EFS	496	O43281
AAALARAAAAGRESP	EID2	81	Q8N6I1
VAAAARGPLDAATAR	HAS1	81	Q92839
PTRTFANGSLAFRVQ	GLMP	181	Q8WWB7
GLALARVRAPSDTTN	MARK4	381	Q96L34
LRPTGFFQRTLSDIA	MCF2L	166	O15068
SAASALNFPFARRAD	MAST3	66	O60307
FSEGRLLSPVVAAAA	DAGLA	736	Q9Y4D2
AASRAAARDSPLAAQ	GRB14	11	Q14449
GQTAPASTRLFQVRA	GSN	556	P06396
SNSGFVRDDNIRLTP	EEF2K	241	O00418
VARAFDSGQNLSPDR	EEF2K	616	O00418
IRISPDNRFLAVGSS	EML6	1776	Q6ZMW3
FSIDPQSGLIRTAAA	CELSR3	376	Q9NYQ7
FRGRAVLIENVASLU	GPX2	26	P18283
PALALEFNRSSVASG	HELZ2	321	Q9BYK8
AAVAFRVSPNSGLLE	DLEC1	1681	Q9Y238
LERGAVFAINFSPAL	DNAH10	656	Q8IVF4
RRLPFAASNIVAGVA	SLC22A3	406	O75751
QADAASGLPRSRLGF	FAM87A	126	P0C7U9
ILSASGTAAVLNPRF	C2CD5	426	Q86YS7
AGRPLVSASALRFEG	MOCS3	196	O95396
ERGSDVASAQLPNFR	SPOUT1	291	Q5T280
FRQRALGTSDSPVLF	INS-IGF2	106	F8WCM5
SDLFPNRSGSRFLAD	MIER2	156	Q8N344
PTAIFAATGIQRNRT	P2RY6	161	Q15077
ILRIPSADGRRNAFS	OR10G6	246	Q8NH81
APARDAARALVNLAA	HGH1	76	Q9BTY7
LDALFAALANGSAPR	GRIN3B	456	O60391
TAARPDQLSFRRGEV	RUSC1	856	Q9BVN2
QASRFPGEAERVAFL	RTL6	126	Q6ICC9
AAAAAASANAKSRRP	RSBN1L	146	Q6PCB5
QRRAPAEARALGAAS	POLG	121	A0A3B3IS91
AAAAAEVEQRRSPGL	RGMB	11	Q6NW40
LNAENPRGTFLVRES	SRC	166	P12931
RVSRLFADAAAALQG	TRIM47	266	Q96LD4
SLLAPERQVGRAAAA	RIN1	356	Q13671
FSAAARARANLPVGT	SLC18A3	266	Q16572
FPFSRALSGAEAVNA	TCAIM	21	Q8N3R3
TLILAAVFPSNSGDR	SLC35F5	281	Q8WV83
RGAIAFALAIRNTES	SLC9A9	441	Q8IVB4
QAPARPAAAFERSLS	TDRD9	61	Q8NDG6
DSRVFVQAALARPSP	TGFBR3L	86	H3BV60
TEGFQRVSAARPNDL	NHS	1271	Q6T4R5
AGDVPAARSILALAF	PRPF6	621	O94906
RAAQVRRAASAAPAS	GNAS	506	Q5JWF2
FTSLGLLPRARFQDS	DHODH	61	Q02127
PGRINARTRAALDAA	SMARCAL1	666	Q9NZC9
SPTAAANFTRRNLAD	PSMB2	76	P49721
LLRPLASVSAQSFGA	RNF13	311	O43567
IAIFADTRPARGGQA	SSTR4	181	P31391
PSGAQRAEAFVRAFL	POP4	21	O95707
AVLLPVSFQEGRRAS	SIK1B	561	A0A0B4J2F2
AVLLPVSFQEGRRAS	SIK1	561	P57059
PVRRFSDGAASIQAF	SIK3	621	Q9Y2K2
RSNAALFQLGSAPAV	NLRP7	351	Q8WX94
ARAALARKGASAPDA	STARD9	906	Q9P2P6
LRGNSFPASLVVAAE	ITGA2B	781	P08514
TASFVARNGPEFEAR	SF3A1	56	Q15459
REQTPLFLAAREGAV	NOTCH4	1766	Q99466
LLGTAQAFRADFTPA	POM121L2	666	Q96KW2
EGRAAPRQSSSFRLL	PDLIM2	231	Q96JY6
LDQAPQGSLSRSRFF	STRC	46	Q7RTU9
AAASSAQARLLQFRP	SOX30	91	O94993
VDFPLRDISLASQRG	SSUH2	296	Q9Y2M2
SSRPQASALELRGFQ	SREBF1	1001	P36956
RLPQFSAEAVRRLAG	ABTB2	116	Q8N961
AARVFRSSPQFGVTL	SLC25A12	581	O75746
LRAFQAAFRAQGPLA	NCAPD2	41	Q15021
DFVALLTGPRSQAVA	CHRD	171	Q9H2X0
RLAIEGLQDSFPARF	CLVS2	181	Q5SYC1
RRNRVSFLGAATVEP	ERVK-25	6	P63136
AAVAQRTAFGRDALP	TJAP1	426	Q5JTD0
GEFRAVRDISVAPLN	XPR1	621	Q9UBH6
ANDTRGRSISFPALL	TRAK2	411	O60296
RRTAQASPNTELDFG	RNF14	156	Q9UBS8
PFDVARNALRLSVGR	SCLY	406	Q96I15
ARAAAAGRFPAQVPS	ZNRF2	41	Q8NHG8
ASPRLAAREGQRFSL	USP43	376	Q70EL4
TPRTEAVFRNLGLQS	TULP2	111	O00295
FSINRRSSAPGQLES	ZSCAN5DP	16	P0CG00
VNADLPSFGRVRESL	TRAPPC11	1016	Q7Z392
VAAGRVASSAFLNAP	RALGAPA1	1216	Q6GYQ0
AADAARSNRVTVFPI	VWF	1811	P04275
ALAARERALASQAPS	SHANK3	1111	Q9BYB0
SRPNASFDRGLSTII	TRO	1321	Q12816
RARAFSVEALVGRPS	TBX22	6	Q9Y458
PTLGRANRFLSTAAV	RNF123	676	Q5XPI4
RLAERAASQGSDSPL	SH3PXD2A	1031	Q5TCZ1
LTFQSPADARAFDRG	SPRED1	101	Q7Z699
AARNLTVPGSLRAVD	TNC	1116	P24821
AQPLLLSTFSGDRRF	GPLD1	701	P80108
ASARFPARTRNLSGE	HIVEP3	2361	Q5T1R4
AFLAQAPSGSRSAEV	ZNF696	26	Q9H7X3
LNEAAARFTLGSPLT	NFATC3	196	Q12968
RRNRVSFLGAATVEP	ERVK-11	6	Q9UQG0
RAARTAPVAGTFGLL	PRRT4	556	C9JH25
DTDAASRRINAPLAA	SNHG28	146	P0DPA3
GVAFPAVFLRSRDTQ	RPAP1	126	Q9BWH6
LVATRSGDPIANAVA	TMOD4	231	Q9NZQ9
PSGELVFLIRRNSFD	TRAV19	61	A0A0A6YYK7
AAAALTPFTVTRRIG	TLX3	141	O43711
ALQRAVFGQPAAVSR	TOR4A	156	Q9NXH8
LRPDGFRSAEAAAAQ	TOR4A	321	Q9NXH8
RNAAGLLRADFPLSV	WFIKKN1	266	Q96NZ8
ETASFLNNGRIPDFR	ZBED6	506	P86452
GRAADAPFVINAIIR	TMEM231	236	Q9H6L2
RTDVNPFLAPRSAAV	TRIP11	1916	Q15643
ERVLSAERPLAAAAG	UBR3	56	Q6ZT12
SANSLRPGALFFSRI	XRCC1	181	P18887
VLSGFQNPFRSELRD	XRCC1	326	P18887
ADCGVAFAQPSRLVR	ZNF648	451	Q5T619
LDQAPQGSLSRSRFF	STRCP1	46	A6NGW2
SGARRFQGSTLPAEA	TRAPPC9	266	Q96Q05
RLTARSQAAAAAAAP	ZNF286B	36	P0CG31
RRNRVSFLGAATVEP	ERVK-19	6	Q9WJR5
NIDLSRLIFPAATSG	XPNPEP2	486	O43895
VAPERLFGSAANVVS	ZBED1	616	O96006
AAALRGPRASVSRAS	TMEM70	26	Q9BUB7
FPGLAADQSRALRLG	SNTB2	146	Q13425
NFRSGSPSALRVLAE	RARRES1	71	P49788
RLDNASAFQGAVISP	PC	406	P11498
FRAPNTDAARSSAQL	ZNF185	331	O15231
GAEEAAQLPLRRASA	WNT2B	6	Q93097
RSFPSVRELGAALQG	TYK2	521	P29597
ATANRLRSAAEPVAS	CSNK1E	336	P49674
GRVSPAAAQLADTLF	KMT2D	4356	O14686
EPRFGSVVRRAANVS	LMF1	356	Q96S06
SRARAFPNGTLEIGV	LRFN4	326	Q6PJG9
FSEVQALPSRGSLAL	LGI3	456	Q8N145
NSDDLSREGNARPIF	MYO9A	1656	B2RTY4